List of Studies ( Metabolite:PA 36:4)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Blood | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003913 | AN006426 | Altered Metabolomics and Inflammatory Transcriptomics in Human Bone Marrow Adipocytes After Acute High Calorie Diet and Acute Fasting | Bone marrow serum | Human | MaineHealth Institute for Research | LC-MS/MS(Dir. Inf.) | |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003575 | AN005870 | Lipidomic Profiling of a Preclinical Model of Streptozotocin induced Diabetic Cardiomyopathy | Blood | Mouse | Cardiovascular disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Blood | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Heart | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003291 | AN005390 | Atopic dermatitis and STAT3 double null mutant skin biopsies during healing. | Skin | Human | Eczema | National Institutes of Health | MALDI-MS |
| ST003090 | AN005055 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | University of Kansas | LC-MS | |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Atria | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Ventricles | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002938 | AN004823 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - part 1 of 2, human plasma | Blood | Human | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002360 | AN003854 | Quantitative lipidomics of TFG-deficient B cells | Cultured cells | Mouse | University of Cologne | MS(Dir. Inf.) | |
| ST002335 | AN003814 | Pathogenic Auxilin mutations affect lipids that are critical to Synaptojanin function | Insect tissue | Fruit fly | Parkinsons disease | VIB-KU Leuven | MS(Dir. Inf.) |
| ST002252 | AN003679 | Lipidomics analysis on Arabidopsis autophagy mutants | Plant | Arabidopsis thaliana | Iowa State University | MS(Dir. Inf.) | |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002140 | AN003502 | Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling flux of the TCA cycle | B-cells | Mouse | University of Erlangen-Nürnberg | LC-MS/MS(Dir. Inf.) | |
| ST002135 | AN003495 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples. (Part 2) | Blood | Human | University of Michigan | LC-MS | |
| ST002134 | AN003491 | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples (Part 1) | Blood | Human | University of Michigan | LC-MS | |
| ST002057 | AN003349 | Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis | Cultured cells | Human | NASH | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001831 | AN002973 | Nested case–control study of environmental exposure within the ongoing Puerto Rico Testsite for Exploring Contamination Threats (PROTECT) pregnancy cohort (part II) | Blood | Human | University of Michigan | LC-MS | |
| ST001292 | AN002150 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001276 | AN002117 | Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001274 | AN002115 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001204 | AN002005 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001202 | AN002001 | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001201 | AN001999 | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001951 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001033 | AN001694 | Determination of mode of action of anti-malalrial drugs using untargeted metabolomics | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000915 | AN001490 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000842 | AN001358 | Muscle and plasma before and after exercise | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000823 | AN001308 | Metabolic profiling of cyst fluid from patients with Intraductal Pancreatic Mucinous Neoplasm (part II) | Cyst fluid | Human | Cancer | University of Michigan | LC-MS |
| ST000776 | AN001226 | Fish Oil distal colon from rats | Colon | Rat | University of Michigan | LC-MS | |
| ST000743 | AN001161 | Metabolomics of bariatric weight loss | Unspecified | Human | Diabetes | University of Michigan | LC-MS |
| ST000688 | AN001061 | Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) | Unspecified | Human | Multiple sclerosis | University of Michigan | LC-MS |
| ST000686 | AN001058 | Lipodomics and Gestational bisphenol A (BPA) exposure | Unspecified | Sheep | University of Michigan | LC-MS | |
| ST000685 | AN001056 | Lipidomics analysis for human liver cell lines | Cultured cells | Human | University of Michigan | LC-MS | |
| ST000676 | AN001038 | Effect of high fat diet and streptozotocin treatment on neuropathy | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000672 | AN001030 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) | Blood | Mouse | Diabetes | University of Michigan | LC-MS |
| ST000662 | AN001010 | Lipidomics of hormone-sensitive lipase variants | Adipose tissue | Human | University of Michigan | LC-MS | |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST000661 | AN001008 | CHOICE clinical weight loss study | Blood | Rat | Obesity | University of Michigan | LC-MS |
| ST000546 | AN000833 | Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium | Cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000539 | AN000819 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash University | LC-MS | |
| ST000414 | AN000656 | Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action | Cells | Plasmodium falciparum | Malaria | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST000403 | AN000643 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences | LC-MS | |
| ST000114 | AN000193 | SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium | B-cells | Human | Cancer | University of Kentucky | GC-MS/LC-MS |
| ST000076 | AN000121 | A549 Cell Study | Lung | Human | University of Kentucky | GC-MS/LC-MS | |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST000004 | AN000005 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |
